Travere Therapeutics, Inc.
US ˙ NasdaqGM ˙ US89422G1076

SecurityTVTX / Travere Therapeutics, Inc.
InstitutionState Board Of Administration Of Florida Retirement System
Latest Disclosed Ownership20,785 shares
Latest Disclosed Value $ 617,522
State Board Of Administration Of Florida Retirement System ownership in TVTX / Travere Therapeutics, Inc.

On May 8, 2026 - State Board Of Administration Of Florida Retirement System filed a 13F-HR form disclosing ownership of 20,785 shares of Travere Therapeutics, Inc. (US:TVTX) valued at $617,522 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 20,785 shares of Travere Therapeutics, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $939,482 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 20,785 0 0.00 618 -22.29 0.0012
2026-02-12 2025-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 20,785 0 0.00 794 60.08 0.0014
2025-11-14 2025-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 20,785 0 0.00 497 61.56 0.0009
2025-08-13 2025-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 20,785 0 0.00 308 -17.47 0.0005
2025-05-12 2025-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 20,785 0 0.00 372 2.76 0.0007
2025-02-10 2024-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 20,785 0 0.00 362 24.83 0.0007
2024-11-08 2024-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 20,785 0 0.00 291 70.59 0.0006
2024-08-08 2024-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 20,785 1,550 8.06 171 -60.65 0.0003
2024-05-08 2024-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 19,235 -1,550 -7.46 433 132.26 0.0010
2024-02-09 2023-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 20,785 0 0.00 187 0.54 0.0004
2023-11-08 2023-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 20,785 100 0.48 186 -41.64 0.0004
2023-08-11 2023-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 20,685 1,450 7.54 318 -26.62 0.0007
2023-06-14 2023-03-31 13F/A-1 TRAVERE THERAPEUTICS COM 89422G107 19,235 0 0.00 433 6.93 0.0010
2023-05-11 2023-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 19,235 0 0 0.0010
2023-06-14 2022-12-31 13F/A-1 TRAVERE THERAPEUTICS COM 89422G107 19,235 -5,320 -21.67 405 -33.22 0.0010
2023-02-07 2022-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 19,235 -5,320 0 0.0010
2022-11-08 2022-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 24,555 0 0.00 605 1.68 0.0016
2022-08-05 2022-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 24,555 0 0.00 595 -6.00 0.0014
2022-05-06 2022-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 24,555 0 0.00 633 -16.93 0.0012
2022-02-08 2021-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 24,555 -483 -1.93 762 25.54 0.0014
2021-11-08 2021-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 25,038 0 0.00 607 66.30 0.0012
2021-08-10 2021-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 25,038 2,273 9.98 365 -35.74 0.0007
2021-05-10 2021-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 22,765 -67,300 -74.72 568 -76.86 0.0011
2021-02-08 2020-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 90,065 0 0.00 2,455 47.62 0.0050
2020-11-09 2020-09-30 13F RETROPHIN COM 761299106 90,065 -28,506 -24.04 1,663 -31.28 0.0038
2020-08-07 2020-06-30 13F RETROPHIN COM 761299106 118,571 91,236 333.77 2,420 506.52 0.0060
2020-05-05 2020-03-31 13F RETROPHIN COM 761299106 27,335 0 0.00 399 2.84 0.0012
2020-02-03 2019-12-31 13F RETROPHIN COM 761299106 27,335 0 0.00 388 22.40 0.0009
2019-11-07 2019-09-30 13F RETROPHIN COM 761299106 27,335 0 0.00 317 -42.26 0.0008
2019-08-05 2019-06-30 13F RETROPHIN COM 761299106 27,335 740 2.78 549 -8.80 0.0014
2019-05-03 2019-03-31 13F RETROPHIN COM 761299106 26,595 0 0.00 602 0.00 0.0016
2019-02-01 2018-12-31 13F RETROPHIN COM 761299106 26,595 0 0.00 602 -21.20 0.0018
2018-10-31 2018-09-30 13F RETROPHIN COM 761299106 26,595 0 0.00 764 5.38 0.0019
2018-08-06 2018-06-30 13F RETROPHIN COM 761299106 26,595 2,790 11.72 725 36.28 0.0019
2018-05-04 2018-03-31 13F RETROPHIN COM 761299106 23,805 0 0.00 532 5.98 0.0015
2018-02-01 2017-12-31 13F RETROPHIN COM 761299106 23,805 160 0.68 502 -14.77 0.0013
2017-10-31 2017-09-30 13F RETROPHIN COM 761299106 23,645 0 0.00 589 28.60 0.0016
2017-08-04 2017-06-30 13F RETROPHIN COM 761299106 23,645 0 0.00 458 5.05 0.0013
2017-05-02 2017-03-31 13F RETROPHIN COM 761299106 23,645 0 0.00 436 -2.68 0.0013
2017-02-07 2016-12-31 13F RETROPHIN COM 761299106 23,645 0 0.00 448 -15.31 0.0014
2016-11-14 2016-09-30 13F RETROPHIN COM 761299106 23,645 160 0.68 529 26.56 0.0016
2016-08-04 2016-06-30 13F RETROPHIN COM 761299106 23,485 4,000 20.53 418 57.14 0.0013
2016-05-04 2016-03-31 13F RETROPHIN COM 761299106 19,485 0 0.00 266 -28.69 0.0010
2016-01-28 2015-12-31 13F RETROPHIN COM 761299106 19,485 180 0.93 373 1.36 0.0014
2015-11-05 2015-09-30 13F RETROPHIN COM 761299106 19,305 19,305 368 0.0014
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.